We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
-3.26%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.39B
AUM Growth
-$185M
(-12%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-8.24%
Top 10 Holdings %
Top 10 Hldgs %
27.7%
Holding
1,055
New
41
Increased
205
Reduced
674
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$734K |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
+$733K |
| 3 |
Antero Resources
AR
|
+$530K |
| 4 |
PDCE
PDC Energy, Inc.
PDCE
|
+$496K |
| 5 |
Healthcare Realty
HR
|
+$469K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.23M |
| 2 |
Microsoft
MSFT
|
+$4.32M |
| 3 |
Chevron
CVX
|
+$3.81M |
| 4 |
ExxonMobil
XOM
|
+$3.28M |
| 5 |
Amazon
AMZN
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.23% |
| 2 | Healthcare | 18.87% |
| 3 | Consumer Discretionary | 11.33% |
| 4 | Communication Services | 9.29% |
| 5 | Energy | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRFS
901
DELISTED
BRF SA
BRFS
| $58K | ﹤0.01% |
24,608
-12,503
| -34% | -$37K |
|
|
MOMO
902
Hello Group
MOMO
$869M
| $56K | ﹤0.01% |
12,191
-5,201
| -30% | -$24.9K |
|
903
Kosmos Energy
KOS
$1.56B
| $55K | ﹤0.01% |
+10,713
| New | +$64.9K |
|
904
Fortuna Silver Mines
FSM
$2.59B
| $54K | ﹤0.01% |
21,422
+2,371
| +12% | +$6.04K |
|
905
Ultrapar
UGP
$6.87B
| $51K | ﹤0.01% |
23,208
-6,655
| -22% | -$16.7K |
|
906
Ginkgo Bioworks
DNA
$481M
| $50K | ﹤0.01% |
400
-222
| -36% | -$26.5K |
|
907
Companhia Siderúrgica Nacional
SID
$1.43B
| $50K | ﹤0.01% |
20,880
-4,328
| -17% | -$11.9K |
|
|
CHS
908
DELISTED
Chicos FAS, Inc.
CHS
| $50K | ﹤0.01% |
10,388
-1,890
| -15% | -$10.5K |
|
909
Nektar Therapeutics
NKTR
$2.39B
| $46K | ﹤0.01% |
954
-1,513
| -61% | -$90K |
|
910
Globalstar
GSAT
$10.2B
| $45K | ﹤0.01% |
1,887
+26
| +1% | +$627 |
|
|
NGD
911
DELISTED
New Gold Inc
NGD
| $44K | ﹤0.01% |
50,047
+5,571
| +13% | +$4.41K |
|
|
EXK
912
Endeavour Silver
EXK
$2.32B
| $42K | ﹤0.01% |
13,913
+2,108
| +18% | +$6.68K |
|
|
CAN
913
Canaan Creative
CAN
$176M
| $37K | ﹤0.01% |
+11,142
| New | +$40.6K |
|
914
IAMGOLD
IAG
$8.47B
| $36K | ﹤0.01% |
33,385
+2,160
| +7% | +$2.88K |
|
915
Pitney Bowes
PBI
$2.42B
| $32K | ﹤0.01% |
13,775
-2,559
| -16% | -$8.21K |
|
|
TELL
916
DELISTED
Tellurian Inc.
TELL
| $29K | ﹤0.01% |
12,106
+1,246
| +11% | +$4.5K |
|
917
Nuvation Bio
NUVB
$2.24B
| $26K | ﹤0.01% |
11,434
+1,304
| +13% | +$3.72K |
|
|
DHC
918
Diversified Healthcare Trust
DHC
$2.26B
| $20K | ﹤0.01% |
19,937
-3,596
| -15% | -$5.76K |
|
|
TDAY
919
USA Today Co
TDAY
$1.23B
| $17K | ﹤0.01% |
11,109
-1,610
| -13% | -$3.91K |
|
920
Senseonics Holdings Inc
SENS
$254M
| $14K | ﹤0.01% |
+543
| New | +$16.6K |
|
|
LOGC
921
DELISTED
ContextLogic
LOGC
| $10K | ﹤0.01% |
458
-55
| -11% | -$2.28K |
|
922
Acadia Pharmaceuticals
ACAD
$4.25B
| – | – |
-16,026
| Closed | -$226K |
|
923
Assured Guaranty
AGO
$3.78B
| – | – |
-4,141
| Closed | -$231K |
|
924
Albany International
AIN
$2.14B
| – | – |
-2,628
| Closed | -$207K |
|
925
Allogene Therapeutics
ALLO
$601M
| – | – |
-10,229
| Closed | -$117K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Profund Advisors held 1,055 positions worth $1.39B, down 12% from $1.57B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Profund Advisors withdrew a net $115M in Q3 2022, closing 134 positions and reducing 674 holdings. Its most notable exit was CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES), an estimated $1.13M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Profund Advisors opened a new position in Apellis Pharmaceuticals worth $847K.
- Profund Advisors's largest Q3 2022 buy was Apellis Pharmaceuticals: 12,407 shares worth $847K.
- Profund Advisors added most to Annaly Capital Management in Q3 2022, an estimated $380K increase.
- Profund Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $6.23M.
- Profund Advisors fully exited CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES) in Q3 2022, selling an estimated $1.13M.
- Profund Advisors's ten largest holdings make up 28% of its $1.39B portfolio in Q3 2022.
- Profund Advisors opened 41 new positions and closed 134 in Q3 2022.
- Profund Advisors's portfolio value fell 12% quarter-over-quarter to $1.39B.
Based on Profund Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.